|
General items
| | | |
|
Title
|
Mentioned randomized or randomly allocation in the title
|
28(8)
|
25(7)
|
|
Authors
|
Reported the contact details of corresponding author, e.g. postal address, email
|
344(99)
|
344(99)
|
|
Trial design
|
Described as "parallel group", "cluster randomized", "crossover", etc.
|
7(2)
|
5(1)
|
|
Trial registration
|
Reported the trial registration number and name of trial register
|
0(0)
|
0(0)
|
|
Funding
|
Reported the source of funding for the trial
|
93(27)
|
0(0)
|
|
Methods
| | | |
|
Participants
|
Reported the details of the participants (included the demography, diagnosis, TCM syndrome)
|
234(68)
|
239(69)
|
|
Interventions
|
Reported the details of the interventions for experimental group (included denomination, usage and course of treatment)
|
163(47)
|
152(44)
|
| |
Reported the details of the interventions for control group (included denomination, usage and course of treatment)
|
179(52)
|
168(49)
|
|
Objective
|
Described as "to compare interventions(A) and (B) in patients with condition(C)"
|
48(14)
|
44(13)
|
|
Outcome
|
Defined the primary outcome
|
11(3)
|
10(3)
|
|
Randomization
|
Reported the method of random sequence generation
|
17(5)
|
14(4)
|
| |
Mentioned the allocation concealment (such as central randomization by telephone)
|
0(0)
|
0(0)
|
|
Blinding
|
Specified exactly who was blinded
|
1(0.3)
|
0(0)
|
| |
Simply mentioned the trial as "single blind", or "double blind"
|
39(11)
|
39(11)
|
|
Results
| | | |
|
Numbers randomized
|
Reported the number of participants randomized to each group
|
253(73)
|
253(73)
|
|
Numbers analyzed
|
Reported the number of participants included in analysis for each group
|
13(4)
|
12(4)
|
|
Outcomes
|
Reported the result for each group (if the primary outcome not defined, reported the result of one listed outcome)
|
195(57)
|
190(55)
|
| |
Reported effect size, precision for the difference between groups
|
2(1)
|
2(1)
|
|
Harms
|
Reported important adverse events or side effects
|
50(15)
|
48(14)
|
|
Conclusions
| | | |
| |
Clearly stated the benefits and harms when interpreting the results
|
4(1)
|
3(1)
|
| |
Only stated the benefits when interpreting the results
|
190(55)
|
190(55)
|
